Azopt and Diabetes - a phase IV clinical study of FDA data

Summary:

Diabetes is reported as a side effect among people who take Azopt (brinzolamide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Xalatan, and have High blood pressure.

The phase IV clinical study analyzes which people have Diabetes when taking Azopt. It is created by eHealthMe based on reports of 7,917 people who have side effects when taking Azopt from the FDA, and is updated regularly.

What is Azopt?

Azopt has active ingredients of brinzolamide. It is often used in glaucoma. eHealthMe is studying from 8,058 Azopt users. Check the latest studies of Azopt.

What is Diabetes?

Diabetes is found to be associated with 2,009 drugs and 2,853 conditions by eHealthMe. Check the latest studies of Diabetes.

On Jul, 12, 2026

7,917 people reported to have side effects when taking Azopt.
Among them, 48 people (0.61%) have Diabetes.

Among these 48 people:

How long have people been on Azopt when they have Diabetes? *

What is the gender of people who have Diabetes when taking Azopt? *

female: 67.39 %
male: 32.61 %

What is the age of people who have Diabetes when taking Azopt? *

What are other drugs people take besides Azopt? *

What are other side effects people have besides Diabetes? *

High Blood Pressure: 14 people, 29.17%
Hypersensitivity: 5 people, 10.42%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 5 people, 10.42%
Drowsiness: 5 people, 10.42%
Visual Impairment: 4 people, 8.33%
Blood Pressure Abnormal: 3 people, 6.25%
Diabetes Mellitus Inadequate Control: 3 people, 6.25%
Eating Disorder: 3 people, 6.25%
Weakness: 3 people, 6.25%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 6.25%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 12.50%
Intraocular Pressure Test Abnormal: 4 people, 8.33%
Intraocular Pressure Increased: 4 people, 8.33%
High Blood Cholesterol: 3 people, 6.25%
Thyroid Diseases: 3 people, 6.25%
Type 2 Diabetes: 3 people, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.17%
Optic Atrophy (the loss of a proportion of optic disc nerve fibres): 2 people, 4.17%
Blood Pressure Abnormal: 2 people, 4.17%
Cardiac Disorder: 2 people, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Azopt and have Diabetes?

- Check whether Diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azopt:

Azopt (8,058 reports)

Diabetes treatments and more:

Diabetes (466,613 reports)

Browse all side effects of Azopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diabetes:

Diabetes (2,009 drugs)

Browse all the conditions that are associated with Diabetes:

Diabetes (2,853 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on brinzolamide (the active ingredients of Azopt) and Azopt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.